{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:31:33Z","timestamp":1792783893118,"version":"4.5.0"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"NIH\/NIAID","award":["U19-AI109762"],"award-info":[{"award-number":["U19-AI109762"]}]}],"content-domain":{"domain":["bmn.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Immunology"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.coi.2018.05.001","type":"journal-article","created":{"date-parts":[[2018,6,22]],"date-time":"2018-06-22T07:46:11Z","timestamp":1529653571000},"page":"196-202","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["The structural basis for filovirus neutralization by monoclonal antibodies"],"prefix":"10.1016","volume":"53","author":[{"given":"Liam B","family":"King","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1399-0117","authenticated-orcid":false,"given":"Brandyn R","family":"West","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon L","family":"Schendel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica Ollmann","family":"Saphire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.coi.2018.05.001_bib0335","series-title":"Outbreaks Chronology: Ebola Virus Disease. Ebola Hemorrhagic Fever","year":"2017"},{"key":"10.1016\/j.coi.2018.05.001_bib0340","series-title":"Marburg Hemorrhagic Fever","author":"Outbreak Table","year":"2014"},{"key":"10.1016\/j.coi.2018.05.001_bib0345","doi-asserted-by":"crossref","first-page":"5256","DOI":"10.1128\/JVI.00232-16","article-title":"Enhancement of Ebola virus infection via ficolin-1 interaction with the mucin domain of GP glycoprotein","volume":"90","author":"Favier","year":"2016","journal-title":"J Virol"},{"key":"10.1016\/j.coi.2018.05.001_bib0350","doi-asserted-by":"crossref","first-page":"8426","DOI":"10.1073\/pnas.1019030108","article-title":"T-cell immunoglobulin and mucin domain 1 (TIM-1) is a receptor for Zaire Ebolavirus and Lake Victoria Marburgvirus","volume":"108","author":"Kondratowicz","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"Suppl. 3","key":"10.1016\/j.coi.2018.05.001_bib0355","doi-asserted-by":"crossref","first-page":"S957","DOI":"10.1093\/infdis\/jir326","article-title":"Ebola virus enters host cells by macropinocytosis and clathrin-mediated endocytosis","volume":"204","author":"Aleksandrowicz","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coi.2018.05.001_bib0360","doi-asserted-by":"crossref","first-page":"e1001121","DOI":"10.1371\/journal.ppat.1001121","article-title":"Ebolavirus is internalized into host cells via macropinocytosis in a viral glycoprotein-dependent manner","volume":"6","author":"Nanbo","year":"2010","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coi.2018.05.001_bib0365","doi-asserted-by":"crossref","first-page":"e1001110","DOI":"10.1371\/journal.ppat.1001110","article-title":"Cellular entry of ebola virus involves uptake by a macropinocytosis-like mechanism and subsequent trafficking through early and late endosomes","volume":"6","author":"Saeed","year":"2010","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coi.2018.05.001_bib0370","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1126\/science.1110656","article-title":"Endosomal proteolysis of the Ebola virus glycoprotein is necessary for infection","volume":"308","author":"Chandran","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.coi.2018.05.001_bib0375","doi-asserted-by":"crossref","first-page":"4174","DOI":"10.1128\/JVI.80.8.4174-4178.2006","article-title":"Role of endosomal cathepsins in entry mediated by the Ebola virus glycoprotein","volume":"80","author":"Schornberg","year":"2006","journal-title":"J Virol"},{"key":"10.1016\/j.coi.2018.05.001_bib0380","doi-asserted-by":"crossref","first-page":"3284","DOI":"10.1128\/JVI.06346-11","article-title":"Filoviruses require endosomal cysteine proteases for entry but exhibit distinct protease preferences","volume":"86","author":"Misasi","year":"2012","journal-title":"J Virol"},{"key":"10.1016\/j.coi.2018.05.001_bib0385","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02154-15","article-title":"Host-primed ebola virus GP exposes a hydrophobic NPC1 receptor-binding pocket, revealing a target for broadly neutralizing antibodies","volume":"7","author":"Bornholdt","year":"2016","journal-title":"MBio"},{"key":"10.1016\/j.coi.2018.05.001_bib0390","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.cell.2015.12.044","article-title":"Ebola viral glycoprotein bound to its endosomal receptor Niemann-Pick C1","volume":"164","author":"Wang","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.coi.2018.05.001_bib0395","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/nature10348","article-title":"Ebola virus entry requires the cholesterol transporter Niemann-Pick C1","volume":"477","author":"Carette","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.coi.2018.05.001_bib0400","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/nature10380","article-title":"Small molecule inhibitors reveal Niemann-Pick C1 is essential for Ebola virus infection","volume":"477","author":"C\u00f4t\u00e9","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.coi.2018.05.001_bib0405","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1038\/emboj.2012.53","article-title":"Ebola virus entry requires the host-programmed recognition of an intracellular receptor","volume":"31","author":"Miller","year":"2012","journal-title":"EMBO J"},{"key":"10.1016\/j.coi.2018.05.001_bib0410","doi-asserted-by":"crossref","first-page":"5034","DOI":"10.1073\/pnas.1200409109","article-title":"Postexposure antibody prophylaxis protects nonhuman primates from filovirus disease","volume":"109","author":"Dye","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coi.2018.05.001_bib0415","doi-asserted-by":"crossref","first-page":"6442","DOI":"10.1128\/JVI.72.8.6442-6447.1998","article-title":"Biochemical analysis of the secreted and virion glycoproteins of Ebola virus","volume":"72","author":"Sanchez","year":"1998","journal-title":"J Virol"},{"key":"10.1016\/j.coi.2018.05.001_bib0420","doi-asserted-by":"crossref","first-page":"11211","DOI":"10.1073\/pnas.1104760108","article-title":"Structure and function of the complete internal fusion loop from ebolavirus glycoprotein 2","volume":"108","author":"Gregory","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coi.2018.05.001_bib0425","doi-asserted-by":"crossref","first-page":"E7987","DOI":"10.1073\/pnas.1708052114","article-title":"Structure of the Ebola virus envelope protein MPER\/TM domain and its interaction with the fusion loop explains their fusion activity","volume":"114","author":"Lee","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coi.2018.05.001_bib0430","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S1097-2765(00)80159-8","article-title":"Crystal structure of the Ebola virus membrane fusion subunit, GP2, from the envelope glycoprotein ectodomain","volume":"2","author":"Weissenhorn","year":"1998","journal-title":"Mol Cell"},{"key":"10.1016\/j.coi.2018.05.001_bib0435","doi-asserted-by":"crossref","first-page":"2662","DOI":"10.1073\/pnas.96.6.2662","article-title":"Core structure of the envelope glycoprotein GP2 from Ebola virus at 1.9-A resolution","volume":"96","author":"Malashkevich","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coi.2018.05.001_bib0440","doi-asserted-by":"crossref","first-page":"46374","DOI":"10.1038\/srep46374","article-title":"Structure of the Ebola virus glycoprotein spike within the virion envelope at 11\u00c5 resolution","volume":"7","author":"Beniac","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.coi.2018.05.001_bib0445","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/nature07082","article-title":"Structure of the Ebola virus glycoprotein bound to an antibody from a human survivor","volume":"454","author":"Lee","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.coi.2018.05.001_bib0450","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.sbi.2009.05.004","article-title":"Neutralizing ebolavirus: structural insights into the envelope glycoprotein and antibodies targeted against it","volume":"19","author":"Lee","year":"2009","journal-title":"Curr Opin Struct Biol"},{"key":"10.1016\/j.coi.2018.05.001_bib0455","doi-asserted-by":"crossref","DOI":"10.1016\/j.chom.2017.12.003","article-title":"The Marburgvirus-neutralizing human monoclonal antibody MR191 targets a conserved site to block virus receptor binding","volume":"23","author":"King","year":"2018","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.coi.2018.05.001_bib0460","doi-asserted-by":"crossref","first-page":"e1005016","DOI":"10.1371\/journal.ppat.1005016","article-title":"Protective mAbs and cross-reactive mAbs raised by immunization with engineered Marburg virus GPs","volume":"11","author":"Fusco","year":"2015","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coi.2018.05.001_bib0465","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/viro.1999.0110","article-title":"Proteolytic processing of Marburg virus glycoprotein","volume":"268","author":"Volchkov","year":"2000","journal-title":"Virology"},{"key":"10.1016\/j.coi.2018.05.001_bib0470","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1126\/science.aad5788","article-title":"Isolation of potent neutralizing antibodies from a survivor of the 2014 Ebola virus outbreak","volume":"351","author":"Bornholdt","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.coi.2018.05.001_bib0475","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2017.04.038","article-title":"Immunization-elicited broadly protective antibody reveals ebolavirus fusion loop as a site of vulnerability","volume":"169","author":"Zhao","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.coi.2018.05.001_bib0480","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.cell.2015.12.022","article-title":"Cross-reactive and potent neutralizing antibody responses in human survivors of natural ebolavirus infection","volume":"164","author":"Flyak","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.coi.2018.05.001_bib0485","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1126\/science.aad5224","article-title":"Protective monotherapy against lethal Ebola virus infection by a potently neutralizing antibody","volume":"351","author":"Corti","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.coi.2018.05.001_bib0490","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1126\/science.287.5458.1664","article-title":"Epitopes involved in antibody-mediated protection from Ebola virus","volume":"287","author":"Wilson","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.coi.2018.05.001_bib0495","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1038\/nsmb.2150","article-title":"A shared structural solution for neutralizing ebolaviruses","volume":"18","author":"Dias","year":"2011","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.coi.2018.05.001_bib0500","doi-asserted-by":"crossref","first-page":"25856","DOI":"10.1038\/srep25856","article-title":"Potent neutralizing monoclonal antibodies against Ebola virus infection","volume":"6","author":"Zhang","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.coi.2018.05.001_bib0505","doi-asserted-by":"crossref","first-page":"20514","DOI":"10.1038\/srep20514","article-title":"Discovery of an antibody for pan-ebolavirus therapy","volume":"6","author":"Furuyama","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.coi.2018.05.001_bib0510","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1128\/JVI.02171-15","article-title":"Pan-ebolavirus and pan-filovirus mouse monoclonal antibodies: protection against Ebola and Sudan viruses","volume":"90","author":"Holtsberg","year":"2015","journal-title":"J Virol"},{"issue":"Suppl. 2","key":"10.1016\/j.coi.2018.05.001_bib0515","doi-asserted-by":"crossref","first-page":"S372","DOI":"10.1093\/infdis\/jiv303","article-title":"Characterization of a novel neutralizing monoclonal antibody against Ebola virus GP","volume":"212","author":"Reynard","year":"2015","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coi.2018.05.001_bib0520","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1093\/infdis\/jit162","article-title":"Profile and persistence of the virus-specific neutralizing humoral immune response in human survivors of Sudan ebolavirus (Gulu)","volume":"208","author":"Sobarzo","year":"2013","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coi.2018.05.001_bib0525","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1128\/JVI.77.2.1069-1074.2003","article-title":"Identification of protective epitopes on Ebola virus glycoprotein at the single amino acid level by using recombinant vesicular stomatitis viruses","volume":"77","author":"Takada","year":"2003","journal-title":"J Virol"},{"key":"10.1016\/j.coi.2018.05.001_bib0530","doi-asserted-by":"crossref","first-page":"6024","DOI":"10.1128\/JVI.73.7.6024-6030.1999","article-title":"Ebola virus can be effectively neutralized by antibody produced in natural human infection","volume":"73","author":"Maruyama","year":"1999","journal-title":"J Virol"},{"key":"10.1016\/j.coi.2018.05.001_bib0535","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.virol.2010.02.029","article-title":"Antibody-mediated neutralization of Ebola virus can occur by two distinct mechanisms","volume":"401","author":"Shedlock","year":"2010","journal-title":"Virology"},{"key":"10.1016\/j.coi.2018.05.001_bib0540","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nature13777","article-title":"Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp","volume":"514","author":"Qiu","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.coi.2018.05.001_bib0545","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1126\/science.aad6117","article-title":"Structural and molecular basis for Ebola virus neutralization by protective human antibodies","volume":"351","author":"Misasi","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.coi.2018.05.001_bib0550","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2017.04.037","article-title":"Antibodies from a human survivor define sites of vulnerability for broad protection against ebolaviruses","volume":"169","author":"Wec","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.coi.2018.05.001_bib0555","unstructured":"Erica Ollmann Saphire, Sharon L. Schendel, Marnie L. Fusco, Karthik Gangavarapu, Bronwyn M. Gunn, et al.: Systematic analysis of monoclonal antibodies against Ebola virus GP defines features that contribute to protection. Cell, in press."},{"key":"10.1016\/j.coi.2018.05.001_bib0560","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1002\/cbic.201200493","article-title":"Two synthetic antibodies that recognize and neutralize distinct proteolytic forms of the Ebola virus envelope glycoprotein","volume":"13","author":"Koellhoffer","year":"2012","journal-title":"ChemBioChem"},{"key":"10.1016\/j.coi.2018.05.001_bib0565","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1128\/JVI.05708-11","article-title":"Cathepsin cleavage potentiates the Ebola virus glycoprotein to undergo a subsequent fusion-relevant conformational change","volume":"86","author":"Brecher","year":"2012","journal-title":"J Virol"},{"key":"10.1016\/j.coi.2018.05.001_bib0570","doi-asserted-by":"crossref","first-page":"e1005373","DOI":"10.1371\/journal.ppat.1005373","article-title":"Induction of cell\u2013cell fusion by Ebola virus glycoprotein: low pH is not a trigger","volume":"12","author":"Markosyan","year":"2016","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coi.2018.05.001_bib0575","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.cell.2015.01.041","article-title":"Structural basis for Marburg virus neutralization by a cross-reactive human antibody","volume":"160","author":"Hashiguchi","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.coi.2018.05.001_bib0580","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3006608","article-title":"Therapeutic intervention of Ebola virus infection in rhesus macaques with the MB-003 monoclonal antibody cocktail","volume":"5","author":"Pettitt","year":"2013","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.coi.2018.05.001_bib0585","doi-asserted-by":"crossref","first-page":"45552","DOI":"10.1038\/srep45552","article-title":"Antibody-dependent-cellular-cytotoxicity-inducing antibodies significantly affect the post-exposure treatment of Ebola virus infection","volume":"7","author":"Liu","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.coi.2018.05.001_bib0590","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00652-17","article-title":"Novel cross-reactive monoclonal antibodies against ebolavirus glycoproteins show protection in a murine challenge model","volume":"91","author":"Duehr","year":"2017","journal-title":"J Virol"},{"key":"10.1016\/j.coi.2018.05.001_bib0595","doi-asserted-by":"crossref","first-page":"3602","DOI":"10.1073\/pnas.93.8.3602","article-title":"The virion glycoproteins of Ebola viruses are encoded in two reading frames and are expressed through transcriptional editing","volume":"93","author":"Sanchez","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coi.2018.05.001_bib0600","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1006\/viro.1995.0052","article-title":"GP mRNA of Ebola virus is edited by the Ebola virus polymerase and by T7 and vaccinia virus polymerases","volume":"214","author":"Volchkov","year":"1995","journal-title":"Virology"},{"key":"10.1016\/j.coi.2018.05.001_bib0605","doi-asserted-by":"crossref","first-page":"16128","DOI":"10.1038\/nmicrobiol.2016.128","article-title":"Structures of Ebola virus GP and sGP in complex with therapeutic antibodies","volume":"1","author":"Pallesen","year":"2016","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.coi.2018.05.001_bib0610","doi-asserted-by":"crossref","first-page":"2972","DOI":"10.1128\/JVI.02151-09","article-title":"Biochemical and structural characterization of cathepsin L-processed Ebola virus glycoprotein: implications for viral entry and immunogenicity","volume":"84","author":"Hood","year":"2010","journal-title":"J Virol"},{"key":"10.1016\/j.coi.2018.05.001_bib0615","doi-asserted-by":"crossref","first-page":"447","DOI":"10.3390\/v4040447","article-title":"Structural basis for differential neutralization of ebolaviruses","volume":"4","author":"Bale","year":"2012","journal-title":"Viruses"},{"key":"10.1016\/j.coi.2018.05.001_bib0620","doi-asserted-by":"crossref","first-page":"17182","DOI":"10.1073\/pnas.1414164111","article-title":"Structures of protective antibodies reveal sites of vulnerability on Ebola virus","volume":"111","author":"Murin","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coi.2018.05.001_bib0625","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1128\/JVI.02172-15","article-title":"Macaque monoclonal antibodies targeting novel conserved epitopes within filovirus glycoprotein","volume":"90","author":"Keck","year":"2015","journal-title":"J Virol"},{"key":"10.1016\/j.coi.2018.05.001_bib0630","doi-asserted-by":"crossref","first-page":"13926","DOI":"10.1038\/srep13926","article-title":"Facile discovery of a diverse panel of anti-Ebola virus antibodies by immune repertoire mining","volume":"5","author":"Wang","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.coi.2018.05.001_bib0635","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1016\/j.celrep.2016.04.026","article-title":"Antibody treatment of Ebola and Sudan virus infection via a uniquely exposed epitope within the glycoprotein receptor-binding site","volume":"15","author":"Howell","year":"2016","journal-title":"Cell Rep"},{"key":"10.1016\/j.coi.2018.05.001_bib0640","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1089\/vim.2014.0068","article-title":"The multiple roles of sGP in Ebola pathogenesis","volume":"28","author":"de La Vega","year":"2015","journal-title":"Viral Immunol"},{"key":"10.1016\/j.coi.2018.05.001_bib0645","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.cell.2015.01.031","article-title":"Mechanism of human antibody-mediated neutralization of Marburg virus","volume":"160","author":"Flyak","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.coi.2018.05.001_bib0650","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aai8711","article-title":"Therapeutic treatment of Marburg and Ravn virus infection in nonhuman primates with a human monoclonal antibody","volume":"9","author":"Mire","year":"2017","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.coi.2018.05.001_bib0655","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/nature18615","article-title":"Toremifene interacts with and destabilizes the Ebola virus glycoprotein","volume":"535","author":"Zhao","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.coi.2018.05.001_bib0660","doi-asserted-by":"crossref","first-page":"10958","DOI":"10.1128\/JVI.00870-14","article-title":"Spatial localization of the Ebola virus glycoprotein mucin-like domain determined by cryo-electron tomography","volume":"88","author":"Tran","year":"2014","journal-title":"J Virol"}],"container-title":["Current Opinion in Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952791518300244?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952791518300244?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T08:46:56Z","timestamp":1760604416000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0952791518300244"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":66,"alternative-id":["S0952791518300244"],"URL":"https:\/\/doi.org\/10.1016\/j.coi.2018.05.001","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.733506993.793559620","asserted-by":"object"}]},"ISSN":["0952-7915"],"issn-type":[{"value":"0952-7915","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The structural basis for filovirus neutralization by monoclonal antibodies","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coi.2018.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}